Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors

Liancheng Fan(Shanghai Jiao Tong University), Jiahua Pan(University of Science and Technology of China), Lixin Zhou(Ministry of Education), Chenfei Chi(Shanghai Jiao Tong University), Yanqing Wang(First Affiliated Hospital of Xiamen University), Yong Huang(Shenyang Jianzhu University), Yiming Gong(Chongqing University), Baijun Dong(Shanghai Jiao Tong University), Xun Shangguan(Shanghai Children's Hospital), Jianjun Sha(Shanghai Jiao Tong University)
BMC Urology
December 1, 2018
Cited by 12


Related Papers